Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Law

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Healthcare Policy = Politiques De Sante|August 24, 2013
Money left on the table: generic drug prices in CanadaMichael R Law
Health Policy (Amsterdam, Netherlands)|April 8, 2014
The characteristics and fulfillment of conditional prescription drug approvals in CanadaMichael R Law
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 21, 2012
The road to competitive generic drug prices in CanadaMichael R Law, Jillian Kratzer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 17, 2021
Policy changes and physicians opting out from Medicare in Quebec: an interrupted time-series analysisDamien Contandriopoulos, Michael R Law
CMAJ Open|July 20, 2019
The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysisAlan Cassels, Michael R Law
CMAJ Open|October 13, 2019
Income-related disparities in private prescription drug coverage in CanadaTalshyn Bolatova, Michael R Law
Journal of Health Economics|July 27, 2010
Is newer always better? Re-evaluating the benefits of newer pharmaceuticalsMichael R Law, Karen A Grépin
Healthcare Policy = Politiques De Sante|May 2, 2012
Purchasing prescription drugs in Canada: hang together or hang separatelyMichael R Law, Steven G Morgan
The American Journal of Psychiatry|April 4, 2007
Cost-effectiveness of schizophrenia pharmacotherapyStephen B Soumerai, Michael R Law
Health Affairs (Project Hope)|August 4, 2020
Compared With Other Countries, Women In The US Are More Likely Than Men To Forgo Medicines Because Of CostJamie R Daw, Michael R Law
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Healthcare Policy = Politiques De Sante|August 24, 2013
Money left on the table: generic drug prices in CanadaMichael R Law
Health Policy (Amsterdam, Netherlands)|April 8, 2014
The characteristics and fulfillment of conditional prescription drug approvals in CanadaMichael R Law
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 21, 2012
The road to competitive generic drug prices in CanadaMichael R Law, Jillian Kratzer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 17, 2021
Policy changes and physicians opting out from Medicare in Quebec: an interrupted time-series analysisDamien Contandriopoulos, Michael R Law
CMAJ Open|July 20, 2019
The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysisAlan Cassels, Michael R Law
CMAJ Open|October 13, 2019
Income-related disparities in private prescription drug coverage in CanadaTalshyn Bolatova, Michael R Law
Journal of Health Economics|July 27, 2010
Is newer always better? Re-evaluating the benefits of newer pharmaceuticalsMichael R Law, Karen A Grépin
Healthcare Policy = Politiques De Sante|May 2, 2012
Purchasing prescription drugs in Canada: hang together or hang separatelyMichael R Law, Steven G Morgan
The American Journal of Psychiatry|April 4, 2007
Cost-effectiveness of schizophrenia pharmacotherapyStephen B Soumerai, Michael R Law
Health Affairs (Project Hope)|August 4, 2020
Compared With Other Countries, Women In The US Are More Likely Than Men To Forgo Medicines Because Of CostJamie R Daw, Michael R Law
Pageof 17